Orchid Pharma Limited (BOM:524372)
India · Delayed Price · Currency is INR 997.45
+20.40 (2.09%)
At close: Aug 21, 2026
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 50.82 billion as of August 21, 2026. Its market cap has increased by 32.24% in one year.
Market Cap
50.82B
Enterprise Value
53.62B
Revenue
8.52B
Ranking
n/a
PE Ratio
172.49
Stock Price
997.45
ChartMarket Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 50.82B, an increase of 6,887.45%. That is a compound annual growth rate of 107.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 50.82B | 32.03% |
| Dec 31, 2025 | 38.49B | -58.00% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Procter & Gamble Health | 95.94B |
| Sanofi India | 75.40B |
| Bliss GVS Pharma | 60.85B |
| FDC Limited | 56.10B |
| Morepen Laboratories | 48.46B |
| Gufic Biosciences | 42.36B |
| Novartis India | 37.82B |
| Unichem Laboratories | 36.03B |